Noninvasive Characterization of Tumor Angiogenesis and Oxygenation in Bevacizumab-treated Recurrent Glioblastoma by Using Dynamic Susceptibility MRI: Secondary Analysis of the European Organization for Research and Treatment of Cancer 26101 Trial

P Kickingereder; G Brugnara; MB Hansen; M Nowosielski; I Pflüger; M Schell; F Isensee; M Foltyn; U Neuberger; T Kessler; F Sahm; A Wick; S Heiland; M Weller; M Platten; A von Deimling; KH Maier-Hein; L Østergaard; Martin van den Bent; T Gorlia; W Wick; M Bendszus

doi:10.1148/radiol.2020200978

Noninvasive Characterization of Tumor Angiogenesis and Oxygenation in Bevacizumab-treated Recurrent Glioblastoma by Using Dynamic Susceptibility MRI: Secondary Analysis of the European Organization for Research and Treatment of Cancer 26101 Trial

P Kickingereder
, G Brugnara
, MB Hansen
, M Nowosielski
, I Pflüger
, M Schell
, F Isensee
, M Foltyn
, U Neuberger
, T Kessler
, F Sahm
, A Wick
, S Heiland
, M Weller
, M Platten
, A von Deimling
, KH Maier-Hein
, L Østergaard
, Martin van den Bent
, T Gorlia

W Wick, M Bendszus

Neurosurgery

Research output: Contribution to journal › Article › Academic › peer-review

30 Citations (Scopus)

Original language	English
Pages (from-to)	164-175
Number of pages	12
Journal	Radiology
Volume	297
Issue number	1
DOIs	https://doi.org/10.1148/radiol.2020200978
Publication status	Published - 2020

Research programs

EMC OR-01

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1148/radiol.2020200978

http://hdl.handle.net/1765/130839

Cite this

Kickingereder, P., Brugnara, G., Hansen, MB., Nowosielski, M., Pflüger, I., Schell, M., Isensee, F., Foltyn, M., Neuberger, U., Kessler, T., Sahm, F., Wick, A., Heiland, S., Weller, M., Platten, M., von Deimling, A., Maier-Hein, KH., Østergaard, L., van den Bent, M., ... Bendszus, M. (2020). Noninvasive Characterization of Tumor Angiogenesis and Oxygenation in Bevacizumab-treated Recurrent Glioblastoma by Using Dynamic Susceptibility MRI: Secondary Analysis of the European Organization for Research and Treatment of Cancer 26101 Trial. Radiology, 297(1), 164-175. https://doi.org/10.1148/radiol.2020200978

@article{6d86eef64b8b44c58fc370c8d67881b2,

title = "Noninvasive Characterization of Tumor Angiogenesis and Oxygenation in Bevacizumab-treated Recurrent Glioblastoma by Using Dynamic Susceptibility MRI: Secondary Analysis of the European Organization for Research and Treatment of Cancer 26101 Trial",

author = "P Kickingereder and G Brugnara and MB Hansen and M Nowosielski and I Pfl{\"u}ger and M Schell and F Isensee and M Foltyn and U Neuberger and T Kessler and F Sahm and A Wick and S Heiland and M Weller and M Platten and \{von Deimling\}, A and KH Maier-Hein and L {\O}stergaard and \{van den Bent\}, Martin and T Gorlia and W Wick and M Bendszus",

year = "2020",

doi = "10.1148/radiol.2020200978",

language = "English",

volume = "297",

pages = "164--175",

journal = "Radiology",

issn = "0033-8419",

publisher = "Radiological Society of North America Inc.",

number = "1",

}

Kickingereder, P, Brugnara, G, Hansen, MB, Nowosielski, M, Pflüger, I, Schell, M, Isensee, F, Foltyn, M, Neuberger, U, Kessler, T, Sahm, F, Wick, A, Heiland, S, Weller, M, Platten, M, von Deimling, A, Maier-Hein, KH, Østergaard, L, van den Bent, M, Gorlia, T, Wick, W & Bendszus, M 2020, 'Noninvasive Characterization of Tumor Angiogenesis and Oxygenation in Bevacizumab-treated Recurrent Glioblastoma by Using Dynamic Susceptibility MRI: Secondary Analysis of the European Organization for Research and Treatment of Cancer 26101 Trial', Radiology, vol. 297, no. 1, pp. 164-175. https://doi.org/10.1148/radiol.2020200978

Noninvasive Characterization of Tumor Angiogenesis and Oxygenation in Bevacizumab-treated Recurrent Glioblastoma by Using Dynamic Susceptibility MRI: Secondary Analysis of the European Organization for Research and Treatment of Cancer 26101 Trial. / Kickingereder, P; Brugnara, G; Hansen, MB et al.
In: Radiology, Vol. 297, No. 1, 2020, p. 164-175.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Noninvasive Characterization of Tumor Angiogenesis and Oxygenation in Bevacizumab-treated Recurrent Glioblastoma by Using Dynamic Susceptibility MRI: Secondary Analysis of the European Organization for Research and Treatment of Cancer 26101 Trial

AU - Kickingereder, P

AU - Brugnara, G

AU - Hansen, MB

AU - Nowosielski, M

AU - Pflüger, I

AU - Schell, M

AU - Isensee, F

AU - Foltyn, M

AU - Neuberger, U

AU - Kessler, T

AU - Sahm, F

AU - Wick, A

AU - Heiland, S

AU - Weller, M

AU - Platten, M

AU - von Deimling, A

AU - Maier-Hein, KH

AU - Østergaard, L

AU - van den Bent, Martin

AU - Gorlia, T

AU - Wick, W

AU - Bendszus, M

PY - 2020

Y1 - 2020

U2 - 10.1148/radiol.2020200978

DO - 10.1148/radiol.2020200978

M3 - Article

C2 - 32720870

SN - 0033-8419

VL - 297

SP - 164

EP - 175

JO - Radiology

JF - Radiology

IS - 1

ER -

Kickingereder P, Brugnara G, Hansen MB, Nowosielski M, Pflüger I, Schell M et al. Noninvasive Characterization of Tumor Angiogenesis and Oxygenation in Bevacizumab-treated Recurrent Glioblastoma by Using Dynamic Susceptibility MRI: Secondary Analysis of the European Organization for Research and Treatment of Cancer 26101 Trial. Radiology. 2020;297(1):164-175. doi: 10.1148/radiol.2020200978